New Jersey's S 3573 regulates pharmacy benefits managers (PBMs) and health insurance carriers to protect patients and pharmacies. The bill directly affects patients, pharmacies, and health plans by banning "steering" (directing patients to affiliated pharmacies), requiring PBMs to charge health plans the same price they pay pharmacies, and prohibiting excessive copays or withholding cost-saving information. Key provisions include banning restrictions on mail-order prescriptions, mandating transparency on price differences between pharmacies and plans, and prohibiting PBMs from sharing patient data for commercial purposes. The law aims to reduce drug costs, expand pharmacy choice, and improve access to care - particularly for rural patients and those with chronic conditions - as highlighted in the legislative findings.
New Jersey Assembly Bill A4439 requires health insurance producers to disclose their total annual revenue from recommended insurance vendors to clients when making policy recommendations. It also mandates health insurance vendors to certify annual direct and indirect compensation paid to producers, including third-party payments tied to recommendations. The bill aligns with existing federal requirements under ERISA for transparency in insurance compensation. This affects health insurance producers, vendors, and their clients in New Jersey, ensuring clearer disclosure of income sources related to insurance sales.
This bill requires certified nurse midwives and physicians in New Jersey to provide pregnant patients with written, evidence-based information about all available birthing options during the initial prenatal visit and before labor begins. The information must cover hospital births, water births, C-sections (scheduled and emergency), associated health risks for mother and infant, effects of medications like epidurals and Pitocin, and insurance coverage options. It must be provided in English and at least seven common non-English languages spoken by patients with limited English proficiency, based on census data. The New Jersey Department of Health will develop this standardized information in consultation with medical professionals and ensure it is accessible in the patient's preferred language.
This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.
This bill requires all health insurance plans and Medicaid in New Jersey to cover medically necessary speech therapy for stuttering, including both habilitative (helping develop speech skills) and rehabilitative (helping regain lost skills) therapy. It applies to all health insurance policies sold in New Jersey, including individual, group, and hospital service contracts, and mandates coverage whether therapy is provided in-person or via telehealth. Insurers must cover these services at the same level as other medical treatments, without additional restrictions. The law directly affects residents with stuttering who rely on insurance for speech therapy, ensuring they receive consistent coverage for this specific treatment.
This bill allows New Jersey state employees without a union representative (due to lack of majority representation) to enroll in specific health care plans under the State Health Benefits Program. Starting January 1, 2025, these employees must choose between the CWA Unity DIRECT or CWA Unity DIRECT2019 plans (or their successors), based on their hire date, for their health coverage. The bill sets the state's and employee's payment obligations for these plans to match the terms of existing collective bargaining agreements that would apply if the employee had union representation. It directly affects state employees without a majority union representative, ensuring they access standardized health plan options.
This bill requires New Jersey physicians to offer patients a test for dihydropyrimidine dehydrogenase deficiency (a condition that can cause dangerous reactions to chemotherapy drugs) before starting chemotherapy. It directly affects patients scheduled for chemotherapy in New Jersey, ensuring they can be screened for this specific risk. The bill mandates that all health insurance policies sold in New Jersey must cover one annual test for this deficiency and any related treatment, at the same level as other medical conditions. This applies to individual, group, and other health insurance plans in the state, with coverage required for both the test and prescribed treatments. The goal is to prevent severe adverse reactions by identifying patients at risk before chemotherapy begins.
This bill restructures the governance of New Jersey's State Health Benefits Program (SHBP), which provides health coverage to state employees. It creates a new 11-member State Health Benefits Commission (replacing the previous structure) and a separate 12-member Plan Design Committee. The Commission includes the Treasurer, agency heads, and members appointed by labor unions representing state employees, while the Plan Design Committee focuses specifically on designing health plan benefits like medical, dental, and prescription coverage. These changes affect all state employees enrolled in the SHBP by altering who oversees their health plan offerings and administration. The bill does not change the actual benefits provided, only the decision-making bodies managing the program.
This New Jersey bill (A 3127) requires Medicare supplement insurance policies sold in the state to include two key provisions: (1) limiting premium increases to once per calendar year, and (2) allowing policyholders to pay their annual premium in advance. It directly affects Medicare supplement insurers and policyholders in New Jersey by setting these specific terms for premium adjustments and payment options. The bill also mandates that insurers file annual rates demonstrating compliance with state loss ratio standards, but the core policy changes focus on consumer protections regarding premium timing. These requirements apply to policies issued or renewed after the bill's effective date.
This bill requires health insurance plans and Medicaid in New Jersey to cover all reproductive health care services, including family planning and abortion. It also prohibits medical malpractice insurers from raising premiums or canceling coverage for providers who offer these legally protected services. The law applies to all health insurance companies, Medicaid, and malpractice insurers operating in the state. By mandating coverage and preventing insurance penalties, the bill aims to remove financial barriers to reproductive health care access for all residents.
